Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

David Crowe

2PUBLICATIONS

30CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Nov 29, 2023

XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies.

Ekta Patel, Natalia V Malkova, David Crowe

|Sep 30, 2022

Assessment of the Immunogenicity Potential for Oligonucleotide-Based Drugs.

Scott P Henry, Cecilia Arfvidsson, Josh Arrington

Pageof 1

Frequent Collaborators

1 joint publications

Adam Vigil

1 joint publications

Ekta Patel

1 joint publications

Natalia V Malkova

1 joint publications

Magali Pederzoli-Ribeil

1 joint publications

Damiano Fantini

1 joint publications

Manoussa Fanny

1 joint publications

Hanumantha Rao Madala

1 joint publications

Kurt A Jenkins

1 joint publications

Oleg Yerov

1 joint publications

Justin Greene

Frequent Collaborators

1 joint publications

Adam Vigil

1 joint publications

Ekta Patel

1 joint publications

Natalia V Malkova

1 joint publications

Magali Pederzoli-Ribeil

Top Related Videos

Evaluation of the <em>In vivo</em> Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the <em>In vivo</em> Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on : Jun 28, 2021

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on : Sep 16, 2018

See more related videos

Top Related Videos

Evaluation of the <em>In vivo</em> Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the <em>In vivo</em> Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on : Jun 28, 2021

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on : Sep 16, 2018

See more related videos